Todd Gray

Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†

Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman et al. · Hepatology · 2010 · 246 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo

Claus G. Roehrborn, Peter Boyle, Donald Bergner et al. · Urology · 1999 · 235 citations

Medicine, Endocrinology, Urology +16

Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study

Funda Meric‐Bernstam, Muralidhar Beeram, Erika Hamilton et al. · The Lancet Oncology · 2022 · 182 citations · Full text

Medicine, Oncology, Pharmacology +17

Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study

Rashmi K. Murthy, Virginia F. Borges, Alison Conlin et al. · The Lancet Oncology · 2018 · 174 citations

Medicine, Oncology, Pharmacology +14

Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced <i>ERBB2/HER2</i>-Positive Metastatic Breast Cancer

Virginia F. Borges, Cristiano Ferrario, Nathalie Aucoin et al. · JAMA Oncology · 2018 · 165 citations · Full text

Medicine, Oncology, Pharmacology +17